Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05796609
Other study ID # DRIVE Test Track
Secondary ID SNCTP000005396
Status Completed
Phase N/A
First received
Last updated
Start date April 5, 2023
Est. completion date August 1, 2023

Study information

Verified date November 2023
Source University of Bern
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To analyze driving behavior of individuals under the influence of alcohol while driving in a real car. Based on the in-vehicle variables, the investigators aim at establishing algorithms capable of discriminating sober and drunk driving using machine learning.


Description:

Driving under the influence of alcohol (or "drunk driving") is one of the most significant causes of traffic accidents. Alcohol consumption impairs neurocognitive and psychomotor function and has been shown to be associated with an increased risk of driving accidents. However, autonomous driving (level 4 or 5) is likely to be broadly available only at a substantially later time point than previously thought due to increasing concerns of safety associated with this technology. Therefore, solutions bridging the upcoming time period by more rapidly and directly addressing the problem of drunk driving associated traffic incidents are urgently needed. On the supposition that driving behavior differs significantly between sober state and drunk state, the investigators assume that different driving patterns of people under alcohol influence compared to sober states can be used to generate drunk driving detection models using machine learning algorithms. In this study, driving for data collection is initially performed at a sober baseline state (no alcohol) and then after alcohol administration (with a target of 0.15 mg/l and 0.35 mg/l breath alcohol concentration).


Recruitment information / eligibility

Status Completed
Enrollment 55
Est. completion date August 1, 2023
Est. primary completion date August 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years and older
Eligibility Inclusion Criteria: - Informed consent as documented by signature. - In possession of a definite Swiss or EU driving license. - At least 21 years old - Active driving in the last 6 months. - No special equipment needed when driving. - Drinks alcohol at least occasionally (moderate/social consumption). - Fluent in (Swiss) German and no speech impairment. Exclusion Criteria: - Health concerns that are incompatible with alcohol consumption. - Any potential participant currently taking illegal drugs or medications that interact with alcohol. - Women who are pregnant or breast feeding. - Intention to become pregnant during the course of the study. - Teetotallers (alcohol abstinent persons). - Alcohol misuse (excessive alcohol consumption habits/risky drinking behaviour (according to WHO definition) and/or the biomarker PEth in capillary blood > 200 ng/mL at first visit. - Known or suspected drug abuse within 4 weeks before the study (e.g., positive urine drug test at first visit). - Non-compliance to alcohol abstinence within 24 hours before the study visits. - Inability to follow the procedures of the study, e.g., due to language problems, psychological disorders, dementia, etc. of the participant. - Participation in another study with investigational drug within the 30 days preceding and during the present study.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Driving under the influence of alcohol
Participants will drive in three different states (sober, drunk above and below the legal limit) on a designated circuit with a real car on a test track accompanied by a driving instructor. After the initial sober driving session, participants are administered pre-mixed alcoholic beverages (e.g., vodka orange). Participants are expected to achieve a target breath alcohol concentration of 0.35 mg/l (legal limit in Switzerland is 0.25 mg/l breath alcohol concentration) before the second driving session starts. Finally, the third driving session starts when the participants' breath alcohol concentration drops to 0.15 mg/l. Participants will be blinded to their alcohol levels during the study. Measurements: Heart rate, respiration rate, blood oxygen saturation, skin conductance, skin temperature, accelerometer, eye movement, radar, facial expression, audio recording, vehicle data, in-cabin gas concentration
Driving under the influence of a placebo
Participants will drive three times at the same intervals as the treatment group on a designated circuit with a real car on a test track accompanied by a driving instructor. After the initial driving session, participants receive placebo beverages (e.g., orange juice with vodka flavor). Participants are fully blinded. Measurements: Heart rate, respiration rate, blood oxygen saturation, skin conductance, skin temperature, accelerometer, eye movement, radar, facial expression, audio recording, vehicle data, in-cabin gas concentration

Locations

Country Name City State
Switzerland Institut für Rechtsmedizin Bern

Sponsors (3)

Lead Sponsor Collaborator
University of Bern ETH Zurich, University of St.Gallen

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Diagnostic accuracy of the drunk driving warning system (DRIVE) to detect states of alcohol influence while driving quantified as the Area Under the Receiver Operator Characteristics Curve (AUROC) The machine learning model is developed and evaluated based on in-vehicle data generated in different states of alcohol intoxication. Detection performance of alcohol influence is quantified as AUROC. 480 minutes
Secondary Diagnostic accuracy of the drunk driving warning system using physiological data to detect states of alcohol influence quantified as the Area Under the Receiver Operator Characteristics Curve (AUROC) The machine learning model is developed and evaluated based on physiological wearable data recorded in different states of alcohol intoxication. Detection performance of alcohol influence is quantified as AUROC. 480 minutes
Secondary Diagnostic accuracy of the drunk driving warning system using eye-tracking data to detect states of alcohol influence quantified as the AUROC The machine learning model is developed and evaluated based on eye-tracking data recorded in different states of alcohol intoxication. Detection performance of alcohol influence is quantified as AUROC. 480 minutes
Secondary Diagnostic accuracy of the drunk driving warning system using controller area network data of the study car to detect states of alcohol influence quantified as the AUROC The machine learning model is developed and evaluated based on controller area network data of the study car recorded in different states of alcohol intoxication. Detection performance of alcohol influence is quantified as AUROC. 480 minutes
Secondary Diagnostic accuracy of the drunk driving warning system using audio data to detect states of alcohol influence quantified as the AUROC The machine learning model is developed and evaluated based on audio data recorded in different states of alcohol intoxication. Detection performance of alcohol influence is quantified as AUROC. 480 minutes
Secondary Diagnostic accuracy of the drunk driving warning system using radar sensor data to detect states of alcohol influence quantified as the AUROC The machine learning model is developed and evaluated based on radar sensor data recorded in different states of alcohol intoxication. Detection performance of alcohol influence is quantified as AUROC. 480 minutes
Secondary Diagnostic accuracy of the drunk driving warning system using gas sensor data to detect states of alcohol influence quantified as the AUROC The machine learning model is developed and evaluated based on gas sensor data recorded in different states of alcohol intoxication. Detection performance of alcohol influence is quantified as AUROC. 480 minutes
Secondary Change of steering over the alcohol intoxication trajectory Steering is recorded based on the controller area network. 480 minutes
Secondary Change of steer torque over the alcohol intoxication trajectory Steer torque is recorded based on the controller area network. 480 minutes
Secondary Change of steer speed over the alcohol intoxication trajectory Steer speed is recorded based on the controller area network. 480 minutes
Secondary Change of velocity over the alcohol intoxication trajectory Velocity is recorded based on the controller area network. 480 minutes
Secondary Change of acceleration over the alcohol intoxication trajectory Acceleration is recorded based on the controller area network. 480 minutes
Secondary Change of braking over the alcohol intoxication trajectory Braking is recorded based on the controller area network. 480 minutes
Secondary Change of swerving over the alcohol intoxication trajectory Swerving is recorded based on the controller area network. 480 minutes
Secondary Change of spinning over the alcohol intoxication trajectory Spinning is recorded based on the controller area network. 480 minutes
Secondary Change of gaze position over the alcohol intoxication trajectory Gaze position is recorded using an eye-tracker device. 480 minutes
Secondary Change of gaze velocity over the alcohol intoxication trajectory Gaze velocity is recorded using an eye-tracker device. 480 minutes
Secondary Change of gaze acceleration over the alcohol intoxication trajectory Gaze acceleration is recorded using an eye-tracker device. 480 minutes
Secondary Change of gaze regions of interest over the alcohol intoxication trajectory Gaze regions of interest (e.g., windshield, car dashboard, etc.) are recorded using an eye-tracker device. 480 minutes
Secondary Change of gaze events over the alcohol intoxication trajectory Gaze events (e.g., fixations, saccades, etc.) are recorded using an eye-tracker device. 480 minutes
Secondary Change of head pose over the alcohol intoxication trajectory Head pose (position/rotation) is recorded using an eye-tracker device. 480 minutes
Secondary Change of heart rate over the alcohol intoxication trajectory Heart rate is recorded using a heart rate monitoring device and wearables. 480 minutes
Secondary Change of heart rate variability over the alcohol intoxication trajectory Heart rate variability is recorded using a heart rate monitoring device and wearables. 480 minutes
Secondary Change of electrodermal activity over the alcohol intoxication trajectory Electrodermal activity is recorded using wearables. 480 minutes
Secondary Change of wrist accelerometer measurements over the alcohol intoxication trajectory Wrist accelerometer measurements are recorded using wearables. 480 minutes
Secondary Change of skin temperature over the alcohol intoxication trajectory Skin temperature is recorded using wearables. 480 minutes
Secondary Self-assessment of driving performance over the alcohol intoxication trajectory Participants rate their driving performance on a 7-point Likert Scale (lower value means poorer driving performance). 480 minutes
Secondary Self-estimation of alcohol concentrations over the alcohol intoxication trajectory Participants estimate their blood alcohol concentration. 480 minutes
Secondary Number of driving mishaps over the alcohol intoxication trajectory Any driving mishaps, accidents and interventions by the driving instructor will be documented. 480 minutes
Secondary Number of Adverse Events (AEs) Adverse Events will be recorded at each study visit. 3 months, from screening to close out visit for each participant
Secondary Number of Serious Adverse Events (SAEs) Serious Adverse Events will be recorded at each study visit. 3 months, from screening to close out visit for each participant.
See also
  Status Clinical Trial Phase
Recruiting NCT05414344 - A Brief Intervention for Alcohol Users With Interpersonal Trauma N/A
Completed NCT05521906 - Evaluation of PRYSHM for LGBTQIA2S+ Youth N/A
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Withdrawn NCT04659278 - Endourage Complete Spectrum Oral Mucosal Drops (OMD) in Adults Desiring a Reduction in Ethanol Use N/A
Not yet recruiting NCT03632408 - Hangover and Residual Zopiclone Effect on Spatial Perception Phase 1
Completed NCT02718508 - An e-Parenting Skills Intervention to Decrease Injured Adolescents' Alcohol Use N/A
Active, not recruiting NCT02629679 - Sports, Education and Consumption of Substances in Adolescents N/A
Completed NCT02945371 - Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life N/A
Completed NCT01553136 - Varenicline Treatment of Alcohol Dependence in Smokers Phase 2
Completed NCT01442753 - Family-Skills Training to Prevent Tobacco and Other Substance Use in Latino Youth N/A
Completed NCT01081119 - Brief Voluntary Alcohol and Drug Intervention for Middle School Youth Phase 2
Completed NCT04510116 - Adults In The Making Prevention Trial N/A
Completed NCT00289965 - Substance Use Risk Education (SURE) Project Phase 2
Completed NCT00506753 - Motivation and Skills for Delta-9-tetrahydrocannabinol/Ethanol (THC/ETOH+) Teens in Jail N/A
Recruiting NCT05288790 - Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT Phase 2
Recruiting NCT05620849 - Young Adult Education on Alcohol & Health N/A
Recruiting NCT04054466 - Nursing Counseling to the Change of Behavior of Alcohol Consumption in Patients in HAART N/A
Recruiting NCT03588754 - Does Propranolol, a Beta Blocker, Attenuate Stress-Induced Drinking? Phase 2
Recruiting NCT06074341 - TeleHealth Resources for IndiVidualizEd Goals (THRIVE) in Alcohol Recovery Study N/A
Terminated NCT04596267 - Pitolisant Effects on Alcohol Self-Administration in Heavy Drinkers Phase 1